Use of fertility drugs and risk of ovarian cancer

Fabio Parazzini, Claudio Pelucchi, Eva Negri, Silvia Franceschi, Renato Talamini, Maurizio Montella, Carlo La Vecchia

Research output: Contribution to journalArticlepeer-review


Background: The potential association between fertility drugs and risk of ovarian cancer has been analysed using data from a case-control study conducted between January 1992 and September 1999 in four Italian areas. Methods: Cases were 1031 women (median age 56, range 18-79 years) with incident, histologically confirmed epithelial ovarian cancer. Controls were 2411 women (median age 57, range 17-79 years) residing in the same geographical areas and admitted to the same network of hospitals for cases for a wide spectrum of acute, non neoplastic, non hormone-related conditions. Results: A total of 15 cases and 26 controls reported use of fertility drugs. The corresponding odds ratio (OR) was 1.3 (95% confidence interval 0.7-2.5). The OR was 1.2 for women reporting last use 25 years. Conclusions: Considering calendar year at use, the OR was non-significantly above unity for women reporting fertility drug use after 1970. The OR was 0.6 among nulliparous women and 1.9 among parous ones.

Original languageEnglish
Pages (from-to)1372-1375
Number of pages4
JournalHuman Reproduction
Issue number7
Publication statusPublished - 2001


  • Fertility drugs
  • Gonadotrophins
  • Ovarian cancer

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynaecology
  • Reproductive Medicine


Dive into the research topics of 'Use of fertility drugs and risk of ovarian cancer'. Together they form a unique fingerprint.

Cite this